Oncternal Therapeutics Cuts Two Programs Amidst Changing BTK Landscape 4/4/2023

Gossamer Cuts Lymphoma Drug After Two Fatalities 4/4/2023

Cure Ventures Launches with $350M to De-Risk Innovation 4/4/2023

Lilly Debuts Next Alzheimer’s Drug, Will Test Subcutaneous Potential 4/4/2023

FDA Approves Keytruda/Padcev Combo in Advanced Urothelial Cancer 4/4/2023

Intellia Seeks to Broaden Gene Editing’s Potential with Full-Spectrum Approach 4/4/2023

Expert Weights In On New FDA AA Guidance for Cancer 4/4/2023

The global shortage of qualified health professionals is an increasing challenge. According to the WHO, an additional 10 million health professionals will be needed by 2030. The demand is particularly acute in low- and middle-income countries, where health systems are already under immense pressure. With the launch of the Partnership for Education of Health Professionals (PEP), the Novo Nordisk Foundation takes a step towards reducing inequity in health by initially targeting the education of health professionals in underserved regions in India and East Africa.

At its annual Pharma Media Day 2023, Bayer presented the latest progress in the ongoing transformation of its pharmaceutical business focusing on accelerating innovative healthcare solutions for the benefits of patients and delivering long-term, sustainable business growth.

Mathai Mammen Finds New Home at FogPharma 3/31/2023

HUTCHMED Completes FDA Submission for High-Potential Colorectal Cancer Drug 3/31/2023

A new artificial intelligence tool can predict the functions of enzymes based on their amino acid sequences, even when the enzymes are unstudied or poorly understood. The researchers said the AI tool, dubbed CLEAN, outperforms the leading state-of-the-art tools in accuracy, reliability and sensitivity. Better understanding of enzymes and their functions would be a boon for research in genomics, chemistry, industrial materials, medicine, pharmaceuticals and more.

Biogen Successfully Targets Tau in Phase Ib Alzheimer's Study 3/30/2023

J&J Drops Out of RSV Race, Cuts Late-Stage Vaccine Candidate 3/30/2023

Bluebird Faces Another Delay with BLA for Sickle Cell Gene Therapy 3/30/2023

GSK Expands Infectious Disease Pipeline With $593M SCYNEXIS Deal 3/30/2023

Court Sides with Vanda Against FDA in Freedom of Information Act Case 3/30/2023

Proximity Bias: Are In-Office Workers at an Advantage Over Remote Workers? 3/30/2023

Top Biotech Licensing Deals of Q1 2023 3/30/2023

Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use - the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose.